Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis
- PMID: 25056328
- PMCID: PMC4187777
- DOI: 10.1128/JCM.01235-14
Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis
Abstract
There are no data about the comparative accuracy of commercially available nucleic acid amplification tests (GeneXpert MTB/RIF and Roche Amplicor) for the diagnosis of tuberculous meningitis (TBM). A total of 148 patients with suspected TBM were evaluated, and cultures served as the reference standard. The sensitivities and specificities (95% confidence interval [CI]) for the Amplicor and Xpert MTB/RIF tests were similar: 46 (31-60) versus 50 (33-67) and 99 (93-100) and 94 (84-99), respectively.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Figures
References
-
- World Health Organization. 2011. Global tuberculosis control 2011. World Health Organization, Geneva, Switzerland
-
- Braunwald E, Fauchi AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. 2001. Harrison's principles of internal medicine, 15th ed, vol 1 McGraw-Hill, New York, NY
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical